spacer
home > ict > spring 2019 > the mosaic of patient engagement
PUBLICATIONS
International Clinical Trials

The Mosaic of Patient Engagement

Patient engagement is a ubiquitous concept in the orphan disease space, yet researchers are still vetting methods to implement more broadly based, efficient, and innovative interactions with patients and caregivers across the R&D spectrum. A wealth of potential engagement mechanisms have been suggested throughout the lifecycle of a potential therapeutic, highlighting both opportunities and challenges that can transform the R&D process.

What motivates someone to participate in a clinical trial? Enabling trial participation may require a fundamental shift in the way the pharmaceutical industry traditionally views the clinical trial process, changing the language commonly used to describe concepts such as patient recruitment and retention by adjusting the frame of reference to emphasise patient engagement. It is the patient’s journey, not the destination, that must take centre stage when a more strategic, rather than transactional, mandate is needed.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Barbara Zupancic is Senior Director of Patient Recruitment and Retention at Worldwide Clinical Trials. With nearly 20 years of experience in clinical research, she is responsible for the patient engagement aspects of clinical trials, which includes making trials more accessible to patients, less burdensome for sites, and smoother for sponsors.

Dr Michael Murphy is Chief Medical and Scientific Officer at Worldwide Clinical Trials. With 30 years of pharma experience, he is responsible for enabling strategic clinical research consultation and protocol development services for Phases 1-4 across therapeutic areas within Worldwide Clinical Trials.
spacer
Barbara Zupancic
spacer
spacer
spacer
Dr Michael Murphy
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Introducing Signant Health [Formerly CRF Bracket] and the Industry’s Most Comprehensive Patient-Centric Suite for Clinical Research

Philadelphia and London – June 10, 2019: CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, today launched as Signant Health (signanthealth.com). Uniting eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite, Signant makes it easier to participate in – and sites and study teams to run – clinical trials. This intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable sponsors and CROs to extend the reach of drug development, expand patient opportunities and improve data quality.
More info >>

White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement